Joshua J. Lim, M.D., is fellowship-trained surgeon with The Minimally Invasive Brain and Spine Center at Mercy.
Mercy's team of cancer doctors diagnose and treat melanoma, a very serious form of skin cancer.
Surgical Oncology at Mercy is recognized throughout the Mid-Atlantic region for its expert cancer surgeons who treat patients with melanoma and abdominal/stomach and/or GI cancer.
Mercy offers emergency care on the Downtown Baltimore campus 24 hours a day, 7 days a week (410-332-9477) with access to a trained emergency medicine team, diagnostic services and consultations with specialists.
In case of an Emergency, Dial 911 and follow the instructions of the EMS (Emergency Medical Services) team.
Mercy Medical Center's downtown campus includes our Main Hospital - The Mary Catherine Bunting Center, McAuley Plaza and The Weinberg Center.
General visiting hours at Mercy are 11:00 am to 8:30 pm. Hours vary by floor, please check with the nursing staff or call 410-332-9555.
Matilda N. Hagan, M.D., is an inflammatory bowel disease (IBD) specialist and Medical Co-Director at The Center for Inflammatory Bowel and Colorectal Diseases, part of The Melissa L. Posner Institute for Digestive Health and Liver Disease at Mercy Medical Center in Baltimore. Dr. Hagan has advanced training in the diagnosis and treatment of Crohn’s Disease and ulcerative colitis. She is highly educated in the use and management of biologic treatment, such as Remicade Infusion, for these debilitating inflammatory bowel diseases.
Dr. Matilda Hagan has been a member of research teams studying Crohn’s Disease and ulcerative colitis. She is dedicated to collaborating with IBD specialists to discuss and explore advanced treatment options for the most complex inflammatory bowel disease cases. Dr. Hagan is co-author of various book chapters regarding gastroenterology conditions.
The Institute for Digestive Health & Liver Disease at Mercy Medical Center brings Baltimore-based top gastroenterologists, doctors, surgeons and specialists to the patient communities of the Mid-Atlantic region with leading treatments for diseases and conditions affecting the digestive tract, including liver and hepatobiliary diseases, inflammatory bowel and colorectal diseases such as Crohn's disease or colitis, conditions of the pancreas, heartburn and reflux disease (GERD), and stomach and intestinal disorders.
Smokers who quit have a 65 percent lower risk of a Crohn's disease flare-up and are less likely to need steroids or other medications.